CN Patent

CN109589325B — 一种用于治疗肠炎的药物组合物及其制备方法

Assigned to Mudanjiang Medical University · Expires 2019-11-26 · 6y expired

What this patent protects

本发明公开了一种治疗用于肠炎的药物组合物及其制备方法，该药物组合物包含3‑[(4‑氯苯基)硫基]‑2‑[6‑(甲基亚磺酰基)吡啶‑3‑基]‑1H‑吡咯并[2,3‑b]吡啶或其药学上可接受的盐和2‑(3‑氟‑苯基)‑环丙烷甲酸(6‑氰基‑1H‑苯并咪唑‑2‑基)‑酰胺或其药学上可接受的盐。该药物组合物在肠炎，特别是溃疡性结肠炎的治疗中具有优异的治疗效果。

USPTO Abstract

本发明公开了一种治疗用于肠炎的药物组合物及其制备方法，该药物组合物包含3‑[(4‑氯苯基)硫基]‑2‑[6‑(甲基亚磺酰基)吡啶‑3‑基]‑1H‑吡咯并[2,3‑b]吡啶或其药学上可接受的盐和2‑(3‑氟‑苯基)‑环丙烷甲酸(6‑氰基‑1H‑苯并咪唑‑2‑基)‑酰胺或其药学上可接受的盐。该药物组合物在肠炎，特别是溃疡性结肠炎的治疗中具有优异的治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN109589325B
Jurisdiction
CN
Classification
—
Expires
2019-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Mudanjiang Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.